ANDA
- noun
- /ˈændə/
- Formal
- Under the ANDA requirements, generic drug makers must show that their drug is the bioequivalent of (the same as) the brand name drug (see details below) -- but they do not have to repeat the drug creators' clinical safety and efficacy trials.
Examples
-
Once the generic drug company submits its ANDA with that Paragraph IV Certification, it has to notify the brand-name manufacturer, who then may immediately sue for patent infringement.
Blog text (18) -
As we've previously discussed (here, here, and here), ViroPharma sued the FDA after the agency denied a March 17, 2006 petition for stay of action and approved ANDAs for generic VANCOCIN.
Blog text (13) -
Filing for the ANDA for MTX is in the 1Q of 2013, but as management says they are way ahead of schedule, I, like others, think it could happen a lot sooner.
Blog text (22) -
Now generic companies submit much simpler Abbreviated New Drug Applications (ANDAs) to the FDA.
Blog text (18) -
The pharmaceutical company submitted an ANDA to the FDA to gain approval for their new generic medication.
-
After reviewing the ANDA, the FDA granted approval for the generic version of the popular drug.
-
Companies must follow strict guidelines when preparing their ANDA to ensure compliance with FDA regulations.
Surface Forms
Morphology
Etymology
ANDA stands for Abbreviated New Drug Application, which is a 'short' application sent to the U.S. Food and Drug Administration to ask for approval to sell a generic drug. So, ANDA is the shorter, simpler form of the full application, which is why it refers to the specific approval request for generics.